In contrast to PARKIN, FBXL4 and its downstream targets thus provide an important example of a clinically relevant mitophagy pathway whose impairment causes severe mitochondrial disease. The gene discussed is FBXL4; the disease is inborn mitochondrial metabolism disorder.